医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.

广告
第一作者: Milind,Javle
第一单位: Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mjavle@mdanderson.org.
作者单位: Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mjavle@mdanderson.org. [1] Mayo Clinic, Scottsdale, AZ, USA. [2] Johns Hopkins University School of Medicine, Baltimore, MD, USA. [3] Moores Cancer Center, University of California San Diego, San Diego, CA, USA. [4] Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Medical College at Cornell University, New York, NY, USA. [5] Medical College of Wisconsin, Milwaukee, WI, USA. [6] Sarah Cannon Research Institute, Nashville, TN, USA; Tennessee Oncology, Nashville, TN, USA. [7] Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. [8] Francis Crick Institute, London, UK; UCL Hospitals, London, UK. [9] Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. [10] Washington University School of Medicine, St Louis, MO, USA. [11] Genentech, South San Francisco, CA, USA. [12]
DOI 10.1016/S1470-2045(21)00336-3
PMID 34339623
发布时间 2021-09-21
提交
  • 浏览1
The Lancet. Oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷